TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from LBT Innovations Limited ( (AU:CC5) ) is now available.
Clever Culture Systems has released its annual report for the year ending June 30, 2025, highlighting the global reach and application of its APAS® Independence technology. The system, distributed exclusively by Thermo Fisher Scientific Inc. in the US and select European countries, is pivotal in automating microbiology processes in laboratories, enhancing efficiency and accuracy in environmental monitoring and infectious disease diagnostics.
More about LBT Innovations Limited
Clever Culture Systems (CCS) provides intelligent automation solutions to microbiology laboratories. Headquartered in Australia, the company has developed the Automated Plate Assessment System (APAS® Independence), which uses artificial intelligence and machine learning to automate the imaging, analysis, and interpretation of microbiology culture plates. It is the only US FDA-cleared AI technology for automated culture plate reading, available in nine countries and used in the pharmaceutical manufacturing sector and clinical laboratories.
Average Trading Volume: 2,453,203
Technical Sentiment Signal: Hold
Current Market Cap: A$62.13M
Learn more about CC5 stock on TipRanks’ Stock Analysis page.